Mogrify looks to transform cell therapy development

cafead

Administrator
Staff member
  • cafead   Jul 01, 2021 at 11:02: AM
via Biotech, Mogrify, recently closed a Series A financing of US$17m, bringing the total raised to US$33m in the round, with the investment set to support the advancement of the company’s immuno-oncology and ophthalmology programs.

article source
 

<